Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1994 1
1995 1
2002 1
2003 2
2005 1
2006 3
2007 1
2008 3
2009 2
2010 1
2011 2
2012 6
2013 3
2014 1
2015 4
2016 4
2017 4
2018 5
2019 7
2020 10
2021 13
2022 8
2023 14
2024 16
2025 10
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.
Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D, Lingvay I, Colhoun HM, Plutzky J, Kosiborod MN, Hovingh GK, Hardt-Lindberg S, Frenkel O, Weeke PE, Rasmussen S, Goudev A, Lang CC, Urina-Triana M, Pietilä M, Lincoff AM; SELECT Trial Investigators. Deanfield J, et al. Lancet. 2024 Aug 24;404(10454):773-786. doi: 10.1016/S0140-6736(24)01498-3. Lancet. 2024. PMID: 39181597 Free article. Clinical Trial.
Adults aged 45 years and older, with a BMI of 27 kg/m(2) or greater and established cardiovascular disease were eligible for the study. ...FINDINGS: Between Oct 31, 2018, and March 31, 2021, 17 604 patients with a mean age of 61.6 years (SD 8.9) and a mean BMI of 33.4 kg/ …
Adults aged 45 years and older, with a BMI of 27 kg/m(2) or greater and established cardiovascular disease were eligible for the stud …
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597. Global Spine J. 2023. PMID: 37222100 Free PMC article. No abstract available.
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2025 May;15(2_suppl):793S-822S. doi: 10.1177/21925682251336882. Epub 2025 May 21. Global Spine J. 2025. PMID: 40397527 Free PMC article. No abstract available.
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.
El Bairi K, Haynes HR, Blackley E, Fineberg S, Shear J, Turner S, de Freitas JR, Sur D, Amendola LC, Gharib M, Kallala A, Arun I, Azmoudeh-Ardalan F, Fujimoto L, Sua LF, Liu SW, Lien HC, Kirtani P, Balancin M, El Attar H, Guleria P, Yang W, Shash E, Chen IC, Bautista V, Do Prado Moura JF, Rapoport BL, Castaneda C, Spengler E, Acosta-Haab G, Frahm I, Sanchez J, Castillo M, Bouchmaa N, Md Zin RR, Shui R, Onyuma T, Yang W, Husain Z, Willard-Gallo K, Coosemans A, Perez EA, Provenzano E, Ericsson PG, Richardet E, Mehrotra R, Sarancone S, Ehinger A, Rimm DL, Bartlett JMS, Viale G, Denkert C, Hida AI, Sotiriou C, Loibl S, Hewitt SM, Badve S, Symmans WF, Kim RS, Pruneri G, Goel S, Francis PA, Inurrigarro G, Yamaguchi R, Garcia-Rivello H, Horlings H, Afqir S, Salgado R, Adams S, Kok M, Dieci MV, Michiels S, Demaria S, Loi S; International Immuno-Oncology Biomarker Working Group. El Bairi K, et al. NPJ Breast Cancer. 2021 Dec 1;7(1):150. doi: 10.1038/s41523-021-00346-1. NPJ Breast Cancer. 2021. PMID: 34853355 Free PMC article. Review.
2-Chloro-benzohydrazide.
Ahmad S, Jabbar A, Hussain MT, Tahir MN. Ahmad S, et al. Acta Crystallogr Sect E Struct Rep Online. 2012 Apr 1;68(Pt 4):o1254. doi: 10.1107/S1600536812012640. Epub 2012 Mar 31. Acta Crystallogr Sect E Struct Rep Online. 2012. PMID: 22606185 Free PMC article.
The asymmetric unit of the the title compound, C(7)H(7)ClN(2)O, contains two mol-ecules in which the chloro-phenyl and the formic hydrazide units are almost planar (r.m.s. deviations of 0.0081 and 0.0100 A, respectively, in one mol-ecule and 0.0069 and 0.0150 A in the othe …
The asymmetric unit of the the title compound, C(7)H(7)ClN(2)O, contains two mol-ecules in which the chloro-phenyl and the formic hydrazide …
2-(4-Bromo-phen-yl)acetohydrazide.
Ahmad S, Jabbar A, Hussain MT, Tahir MN. Ahmad S, et al. Acta Crystallogr Sect E Struct Rep Online. 2012 Jul 1;68(Pt 7):o2269. doi: 10.1107/S1600536812027006. Epub 2012 Jun 30. Acta Crystallogr Sect E Struct Rep Online. 2012. PMID: 22798917 Free PMC article.
In the title compound, C(8)H(9)BrN(2)O, the 1-bromo-4-methyl-benzene group and the formic hydrazide moiety [r.m.s. deviations of 0.0129 and 0.0038 A] are oriented at a dihedral angle of 80.66 (11) . ...
In the title compound, C(8)H(9)BrN(2)O, the 1-bromo-4-methyl-benzene group and the formic hydrazide moiety [r.m.s. deviations of 0.01 …
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study.
European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC). European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC). Lancet Diabetes Endocrinol. 2024 Nov;12(11):811-823. doi: 10.1016/S2213-8587(24)00221-3. Epub 2024 Oct 4. Lancet Diabetes Endocrinol. 2024. PMID: 39374602 Free article.
The main outcome was prevalence of type 2 diabetes overall and by WHO region, and in relation to obesity (BMI 30.0 kg/m(2)) and lipid-lowering medication as predictors. The study population was divided into 12 risk categories based on age (tertiles), obesity, and receivin …
The main outcome was prevalence of type 2 diabetes overall and by WHO region, and in relation to obesity (BMI 30.0 kg/m(2)) and lipi …
Deguelin exerts potent nematocidal activity via the mitochondrial respiratory chain.
Preston S, Korhonen PK, Mouchiroud L, Cornaglia M, McGee SL, Young ND, Davis RA, Crawford S, Nowell C, Ansell BRE, Fisher GM, Andrews KT, Chang BCH, Gijs MAM, Sternberg PW, Auwerx J, Baell J, Hofmann A, Jabbar A, Gasser RB. Preston S, et al. FASEB J. 2017 Oct;31(10):4515-4532. doi: 10.1096/fj.201700288R. Epub 2017 Jul 7. FASEB J. 2017. PMID: 28687609
-Preston, S., Korhonen, P. K., Mouchiroud, L., Cornaglia, M., McGee, S. L., Young, N. D., Davis, R. A., Crawford, S., Nowell, C., Ansell, B. R. E., Fisher, G. M., Andrews, K. T., Chang, B. C. H., Gijs, M. A. M., Sternberg, P. W., Auwerx, J., Baell, J., …
-Preston, S., Korhonen, P. K., Mouchiroud, L., Cornaglia, M., McGee, S. L., Young, N. D., Davis, R. A., Crawford, S., Nowell, C., Ans …
119 results